ALSERES PHARMACEUTICALS INC: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2013)
- $473.7K
- Net Income/Loss (FY2013)
- -$941.5K
- Total Assets (FY2013)
- $385.5K
- Total Equity (FY2013)
- -$10.7M
- Cash Flows from Operating Activities (FY2013)
- -$1.7M
Source: ALSERES PHARMACEUTICALS INC 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
